Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and increases P-ERK1/2 expression in HL-60 cells in vitro. GP 1a is beneficial for skin wound healing. GP 1a inhibits inflammation and fibrogenesis while promoting epithelial re-formation.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 12,000 | |||
5 mg | 在庫あり | ¥ 26,000 | |||
10 mg | 在庫あり | ¥ 41,000 | |||
25 mg | 在庫あり | ¥ 82,500 | |||
50 mg | 在庫あり | ¥ 122,500 | |||
100 mg | 在庫あり | ¥ 174,500 | |||
500 mg | 在庫あり | ¥ 351,500 |
説明 | GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and increases P-ERK1/2 expression in HL-60 cells in vitro. GP 1a is beneficial for skin wound healing. GP 1a inhibits inflammation and fibrogenesis while promoting epithelial re-formation. |
分子量 | 441.35 |
分子式 | C23H22Cl2N4O |
CAS No. | 511532-96-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 90.0 mg/mL (203.9 mM)
DMSO: 90.0 mg/mL (203.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GP 1a 511532-96-0 Apoptosis GPCR/G Protein Cannabinoid Receptor PERK Arrestin Inhibitor inhibitor inhibit